1. Home
  2. JFIN vs CVRX Comparison

JFIN vs CVRX Comparison

Compare JFIN & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JFIN

Jiayin Group Inc.

HOLD

Current Price

$4.89

Market Cap

247.1M

Sector

Finance

ML Signal

HOLD

Logo CVRx Inc.

CVRX

CVRx Inc.

HOLD

Current Price

$7.86

Market Cap

237.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JFIN
CVRX
Founded
2011
2000
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
247.1M
237.1M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
JFIN
CVRX
Price
$4.89
$7.86
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$10.50
AVG Volume (30 Days)
40.7K
258.4K
Earning Date
06-03-2026
05-11-2026
Dividend Yield
17.47%
N/A
EPS Growth
N/A
23.02
EPS
N/A
N/A
Revenue
N/A
$56,651,000.00
Revenue This Year
N/A
$17.17
Revenue Next Year
N/A
$17.69
P/E Ratio
$1.35
N/A
Revenue Growth
N/A
10.45
52 Week Low
$3.70
$4.37
52 Week High
$18.70
$11.30

Technical Indicators

Market Signals
Indicator
JFIN
CVRX
Relative Strength Index (RSI) 53.01 51.00
Support Level $3.70 $6.74
Resistance Level $5.00 $8.09
Average True Range (ATR) 0.21 0.55
MACD 0.09 0.02
Stochastic Oscillator 83.19 79.64

Price Performance

Historical Comparison
JFIN
CVRX

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: